- PLN163.56m
- PLN120.25m
- PLN151.68m
- 43
- 75
- 27
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.26 | ||
| Price to Tang. Book | 1.27 | ||
| Price to Free Cashflow | 10.7 | ||
| Price to Sales | 1.48 | ||
| EV to EBITDA | 4.51 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.8% | ||
| Return on Equity | 8.25% | ||
| Operating Margin | 15.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | n/a | n/a | 56.87 | 163.98 | 151.68 | 66.07 | 35.67 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +945.69 | +121.38 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mabion SA is a Poland-based biopharmaceutical company. The Company provides a broad spectrum of services in the segment of small and medium-sized projects at various stages of development (from early-stage discovery to commercial manufacturing). The Company's competencies include the selection of protein expression technologies, their purification, GMP-standard manufacturing activities (obtaining Active Substances - Drug Substance and Finished Products - Drug Product), development of analytical tools (for structural, functional, physicochemical characterization), clinical development, clinical analytics and a full range of regulatory activities in the development and operational areas. The Company's goal is to establish itself as a recognizable player in the global contract manufacturing and contract drug development market and to complete its full transformation into an integrated biologics CDMO company.
Directors
- Dirk Kreder PRE
- Jolanta Baranowska CAO
- Grzegorz Grabowicz MGB
- Slawomir Jaros MGB
- David James IND
- Robert Konski IND (53)
- Jozef Banach SUB
- Slawomir Kosciak SUB
- Zofia Szewczuk SUB
- Wojciech Wosko SUB
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- October 29th, 2009
- Public Since
- August 10th, 2010
- No. of Employees
- 226
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange- Shares in Issue
- 16,162,326
- Address
- gen. Mariana Langiewicza 60, KONSTANTYNOW LODZKI, 95-050
- Web
- https://www.mabion.eu/
- Phone
- +48 422077890
- Contact
- Michal Wierzchowski
- Auditors
- PricewaterhouseCoopers Polska sp. z o.o. Audyt sp.k.
Upcoming Events for MAB
Mabion SA Annual Shareholders Meeting
Half Year 2025 Mabion SA Earnings Release
Similar to MAB
Bioton SA
Warsaw Stock Exchange
Braster SA
Warsaw Stock Exchange
Captor Therapeutics SA
Warsaw Stock Exchange
Genomed SA
Warsaw Stock Exchange
Genomtec SA
Warsaw Stock Exchange
FAQ
What is the Mabion SA share price?
As of Today at 21:50 UTC, shares in Mabion SA are trading at PLN10.12. This share price information is delayed by 15 minutes.
How has the Mabion SA share price performed this year?
Shares in Mabion SA last closed at PLN10.12 and the price had moved by -34.62% over the past 365 days. In terms of relative price strength the Mabion SA share price has underperformed the FTSE Global All Cap Index by -36.26% over the past year.
What are the analyst and broker recommendations for Mabion SA?
The overall consensus recommendation for Mabion SA is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Mabion SA dividend yield?
Mabion SA does not currently pay a dividend.
Does Mabion SA pay a dividend?
Mabion SA does not currently pay a dividend.
When does Mabion SA next pay dividends?
Mabion SA does not currently pay a dividend.
How do I buy Mabion SA shares?
To buy shares in Mabion SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Mabion SA?
As of the previous close price of PLN10.12, shares in Mabion SA had a market capitalisation of PLN163.56m.
Where are Mabion SA shares listed?
Here are the trading details for Mabion SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MAB
What kind of share is Mabion SA?
Based on an overall assessment of its quality, value and momentum Mabion SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Mabion SA share price forecast for 2025?
The analyst consensus target price for shares in Mabion SA is PLN8.17. That is 19.27% below the last closing price of PLN10.12.
Analysts covering Mabion SA currently have a consensus Earnings Per Share (EPS) forecast of -PLN0.16 for the next financial year.
Find out moreWhat is the trend in the Mabion SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mabion SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -31.21%.
As of the last closing price of PLN10.12, shares in Mabion SA were trading -22.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Mabion SA PE Ratio?
The Mabion SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN10.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Mabion SA?
Mabion SA's management team is headed by:
- Dirk Kreder - PRE
- Jolanta Baranowska - CAO
- Grzegorz Grabowicz - MGB
- Slawomir Jaros - MGB
- David James - IND
- Robert Konski - IND
- Jozef Banach - SUB
- Slawomir Kosciak - SUB
- Zofia Szewczuk - SUB
- Wojciech Wosko - SUB